Ergothioneine: The "Longevity Vitamin"? An Evidence-Graded Review

Ergothioneine has one of the most seductive stories in the longevity-supplement world: a compound your body actively hoards using a dedicated transporter, that you can only get from your diet, that falls as you age, and that tracks with lower mortality in a respected cardiology journal. A famous review even floated it as a candidate "longevity vitamin." Put together, that sounds close to proof. It isn't — and the gap between the strength of the association and the total absence of an outcome trial is the whole story. This page walks through what's genuinely impressive about ergothioneine and where the evidence quietly runs out. For the wider map of what's earned its place versus what's hype, start with our pillar on longevity medicine: what's proven vs hyped.

What ergothioneine is

Ergothioneine is a sulfur-containing amino acid derivative — a naturally occurring antioxidant that humans cannot synthesize. We get it entirely from diet, and the richest sources by far are mushrooms (especially oyster, shiitake, and king oyster), with smaller amounts in some beans, organ meats, and grains grown in ergothioneine-producing soil fungi. What sets it apart from ordinary dietary antioxidants is that the body treats it specially: a dedicated, highly specific transporter (OCTN1, encoded by SLC22A4) actively pumps ergothioneine into cells and concentrates it in tissues exposed to oxidative stress — liver, kidney, blood cells, the lens of the eye, and the brain. Biologists generally read "the body built a dedicated transporter to retain this molecule" as a sign it does something useful. That inference is reasonable. It is not, by itself, evidence of a longevity benefit.

The "longevity vitamin" idea

The phrase that powers most ergothioneine marketing comes from Bruce Ames's 2018 framework of longevity vitamins and proteins — micronutrients whose shortfall doesn't cause an obvious acute deficiency disease, but which Ames hypothesized are quietly rationed by the body toward short-term survival at the expense of long-term health and lifespan¹. Ergothioneine was put forward as a leading candidate for this category. Bernard Halliwell, one of the field's central figures, has argued the same case in detail — that ergothioneine is a diet-derived antioxidant with genuine therapeutic potential and the hallmarks of a conditionally essential nutrient²³. This is a serious, well-argued hypothesis from credible scientists. But "a respected researcher proposed it might be a longevity vitamin" is a hypothesis statement, not a demonstrated outcome — and the honest reading is that ergothioneine has the profile of something important without the trial data to confirm it.

The mortality association: real, and genuinely strong

The single most-cited piece of human evidence is a 2020 study in Heart by Smith and colleagues, drawn from a Swedish population cohort with long follow-up. People with higher blood ergothioneine had a significantly lower risk of all-cause mortality and of dying from cardiovascular disease, and the association survived adjustment for conventional risk factors⁴. As epidemiology goes, that's a strong, clean signal in a well-characterized cohort — exactly the kind of result that makes a molecule worth investigating. Supporting it from a different angle, large prospective analyses of U.S. adults found that higher mushroom consumption — the dominant dietary source of ergothioneine — was associated with lower all-cause mortality⁵. Two independent lines of population data pointing the same way is more than most longevity supplements can claim.

But here is the load-bearing caveat, and it's the reason the grade below is what it is: this is association, not causation. Ergothioneine is overwhelmingly a marker of a mushroom-and-plant-rich, higher-quality diet. People who eat that way differ in dozens of ways — more fiber, more vegetables, often more exercise, less smoking, higher socioeconomic status — that an observational study can adjust for only imperfectly. A higher ergothioneine level may simply be a biomarker of eating well, not an independent cause of living longer. The 2020 authors themselves framed it as an association worth testing, not a proven intervention⁴. Until someone randomizes people to ergothioneine versus placebo and measures outcomes, the most defensible interpretation is that ergothioneine is, in large part, a healthy-diet proxy.

The aging and cognition angle

Two further findings are often stacked onto the longevity claim. First, blood ergothioneine declines with age: a Singapore study found levels fell in older adults and were lower in people with mild cognitive impairment⁶. Second, in a separate elderly cohort, low plasma ergothioneine predicted subsequent cognitive and functional decline⁷, and a 2025 systematic review concluded the observational link between ergothioneine status and better cognitive aging is consistent across studies⁸. Taken together these make ergothioneine look like a plausible player in brain aging.

The catch is identical to the mortality story. "Levels fall with age and low levels track worse outcomes" is precisely the pattern you'd expect from a biomarker of a declining, less-varied diet in frailer older people — reverse causation and confounding are wide open. It is suggestive, mechanism-consistent, and unproven. The catalogued hallmarks of aging include loss of proteostasis and chronic oxidative and inflammatory stress⁹, and ergothioneine's antioxidant chemistry plausibly touches several — but "plausibly touches a hallmark" is a hypothesis about humans, not a result in them.

The missing piece: no interventional outcome trial

Strip away the mechanism and the associations and you arrive at the fact the marketing never leads with: there is no randomized controlled trial showing ergothioneine supplementation extends human lifespan, prevents cardiovascular events, or slows cognitive decline. The human interventional data that exist are small and short. A controlled study in healthy volunteers established that oral ergothioneine is absorbed, retained, and distributed into tissues with very low excretion, and was well tolerated — important pharmacokinetic and safety groundwork¹⁰. But that is an uptake-and-safety study, not an outcomes trial. Nobody has yet shown that adding ergothioneine to a person's diet changes whether or how long they live. Everything load-bearing in the longevity pitch is either mechanism, animal/cell data, or association.

Safety

On safety the picture is reassuring, which is part of why ergothioneine is an easy supplement to recommend casually. It's a normal dietary constituent, it has a dedicated retention system suggesting the body is built to handle it, and the human uptake study found it well tolerated with no adverse signals at the doses used¹⁰. Regulators in the EU and elsewhere have granted synthetic ergothioneine novel-food/GRAS-type clearances for use in foods, reflecting a benign acute safety profile. As always, that's a different claim from efficacy: "safe at studied doses" is not "proven to extend life," and long-term high-dose supplementation specifically for anti-aging hasn't been formally studied. The cheapest, best-evidenced way to raise your ergothioneine is also the least controversial — eat more mushrooms, which carries its own independent mortality association⁵.

The grade

The bottom line

Ergothioneine is the most interesting unproven longevity candidate on this site, and that tension is the point. It has a dedicated transporter, a credible "longevity vitamin" hypothesis from serious scientists, a strong and replicated association with lower mortality and better cognitive aging, and a benign safety profile. What it does not have is a single randomized trial showing that taking it changes an outcome — and its biggest confounder is that ergothioneine is largely a marker of eating a mushroom- and plant-rich diet. That combination earns it a Grade C: a strong association resting on no causal proof, with a healthy-diet explanation that hasn't been ruled out. If you want the upside, the honest move is to get it the way the mortality data actually came — from food, by eating more mushrooms — rather than betting on a pill to do something no trial has shown it does. For where supplements like this fit on the evidence ladder, see our best longevity supplements, rated by evidence roundup, and compare ergothioneine's case to two other diet-derived molecules with suggestive-but-unproven longevity stories: taurine for longevity and spermidine for longevity. For programs that pair supplements with real clinical oversight, see our graded best longevity clinics hub.